Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Genetics

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    June 2022
  1. HOL JA, Kuiper RP, van Dijk F, Waanders E, et al
    Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.
    J Clin Oncol. 2022;40:1892-1902.
    PubMed     Abstract available


    April 2022
  2. KURRECK A, Stintzing S, Modest DP
    Efficacy, Molecular Biology, Quality of Life, or Economic Aspects: What Do We Really FOCUS oN?
    J Clin Oncol. 2022;40:1260-1262.
    PubMed    


  3. CHAKRAVARTY D, Johnson A, Sklar J, Lindeman NI, et al
    Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion.
    J Clin Oncol. 2022;40:1231-1258.
    PubMed     Abstract available


    February 2022
  4. CARLOS RC, Obeng-Gyasi S, Cole SW, Zebrack BJ, et al
    Linking Structural Racism and Discrimination and Breast Cancer Outcomes: A Social Genomics Approach.
    J Clin Oncol. 2022 Feb 2:JCO2102004. doi: 10.1200/JCO.21.02004.
    PubMed    


    December 2021
  5. SABNIS HS, Shulman DS, Mizukawa B, Bouvier N, et al
    Multicenter Analysis of Genomically Targeted Single Patient Use Requests for Pediatric Neoplasms.
    J Clin Oncol. 2021;39:3822-3828.
    PubMed     Abstract available


    November 2021
  6. NAZHA A, Komrokji R, Meggendorfer M, Jia X, et al
    Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes.
    J Clin Oncol. 2021;39:3737-3746.
    PubMed     Abstract available


    October 2021
  7. ADEMUYIWA FO, Salyer P, Tao Y, Luo J, et al
    Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast Oncologists.
    J Clin Oncol. 2021 Oct 18:JCO2101426. doi: 10.1200/JCO.21.01426.
    PubMed     Abstract available


    September 2021
  8. MASCARENHAS L
    A Step Forward in Realizing the Promise of Genomic Medicine for Childhood Rhabdomyosarcoma.
    J Clin Oncol. 2021;39:2851-2854.
    PubMed    


  9. SHERN JF, Selfe J, Izquierdo E, Patidar R, et al
    Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.
    J Clin Oncol. 2021;39:2859-2871.
    PubMed     Abstract available


    April 2021
  10. BERSANELLI M, Travaglino E, Meggendorfer M, Matteuzzi T, et al
    Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.
    J Clin Oncol. 2021;39:1223-1233.
    PubMed     Abstract available


  11. MURPHY AB, Abern MR, Liu L, Wang H, et al
    Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population With Favorable-Risk Prostate Cancer: A Randomized Trial.
    J Clin Oncol. 2021 Apr 9:JCO2002997. doi: 10.1200/JCO.20.02997.
    PubMed     Abstract available


    February 2021
  12. CREW KD, Hershman DL
    Better Together: Clinical and Genomic Data to Inform Shared Decision Making.
    J Clin Oncol. 2021;39:545-547.
    PubMed    


    January 2021
  13. KUMAR R, Smith KS, Deng M, Terhune C, et al
    Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.
    J Clin Oncol. 2021 Jan 27:JCO2001359. doi: 10.1200/JCO.20.01359.
    PubMed     Abstract available


  14. KALINSKY K, Thomas A, Cescon DW
    On the Road to Precision: Understanding the Biology Driving Genomic Assays.
    J Clin Oncol. 2021;39:100-102.
    PubMed    


  15. GAJJAR A, Robinson GW, Smith KS, Lin T, et al
    Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
    J Clin Oncol. 2021 Jan 6:JCO2001372. doi: 10.1200/JCO.20.01372.
    PubMed     Abstract available


    November 2020
  16. AMBROS IM, Tonini GP, Potschger U, Gross N, et al
    Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.
    J Clin Oncol. 2020;38:3685-3697.
    PubMed     Abstract available


    October 2020
  17. CROMBIE JL, Armand P
    Diffuse Large B-Cell Lymphoma's New Genomics: The Bridge and the Chasm.
    J Clin Oncol. 2020;38:3565-3574.
    PubMed    


    July 2020
  18. LONIAL S, Dhodapkar MV, Rajkumar SV
    Smoldering Myeloma and the Art of War.
    J Clin Oncol. 2020;38:2363-2365.
    PubMed    


  19. BUSTOROS M, Sklavenitis-Pistofidis R, Park J, Redd R, et al
    Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression.
    J Clin Oncol. 2020;38:2380-2389.
    PubMed     Abstract available


    May 2020
  20. LIN DW, Zheng Y, McKenney JK, Brown MD, et al
    17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort.
    J Clin Oncol. 2020;38:1549-1557.
    PubMed     Abstract available


  21. KURIAN AW, Katz SJ
    Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control.
    J Clin Oncol. 2020;38:1371-1374.
    PubMed    


  22. FREY MK, Kahn RM, Chapman-Davis E, Tubito F, et al
    Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.
    J Clin Oncol. 2020;38:1389-1397.
    PubMed     Abstract available


    April 2020
  23. ROBINSON GW, Gajjar A
    Genomics Paves the Way for Better Infant Medulloblastoma Therapy.
    J Clin Oncol. 2020 Apr 30:JCO2000593. doi: 10.1200/JCO.20.00593.
    PubMed    


  24. TREON SP, Xu L, Guerrera ML, Jimenez C, et al
    Genomic Landscape of Waldenstrom Macroglobulinemia and Its Impact on Treatment Strategies.
    J Clin Oncol. 2020;38:1198-1208.
    PubMed     Abstract available


    March 2020
  25. FREEMAN S, Craddock C
    Less Is Not Necessarily More: Toward a Rational Selection of the Conditioning Regimen in Acute Myeloid Leukemia.
    J Clin Oncol. 2020 Mar 2:JCO1903161. doi: 10.1200/JCO.19.03161.
    PubMed    


    February 2020
  26. HASSETT MJ, Somerfield MR, Baker ER, Cardoso F, et al
    Management of Male Breast Cancer: ASCO Guideline.
    J Clin Oncol. 2020 Feb 14:JCO1903120. doi: 10.1200/JCO.19.03120.
    PubMed     Abstract available


    January 2020
  27. KONSTANTINOPOULOS PA, Norquist B, Lacchetti C, Armstrong D, et al
    Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
    J Clin Oncol. 2020 Jan 27:JCO1902960. doi: 10.1200/JCO.19.02960.
    PubMed     Abstract available


  28. PATEL JN, McLeod HL
    Clarity Also Needed for Direct-to-Consumer Pharmacogenetic Tests.
    J Clin Oncol. 2020;38:283-284.
    PubMed    


    December 2019
  29. HAYES DF, Rae JM
    Pharmacogenomics and Endocrine Therapy in Breast Cancer.
    J Clin Oncol. 2019 Dec 27:JCO1903119. doi: 10.1200/JCO.19.03119.
    PubMed    


  30. EGGENER SE, Rumble RB, Armstrong AJ, Morgan TM, et al
    Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline.
    J Clin Oncol. 2019 Dec 12:JCO1902768. doi: 10.1200/JCO.19.02768.
    PubMed     Abstract available


    June 2019
  31. GOETZ MP, Suman VJ, Nakamura Y, Kiyotani K, et al
    Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAM.
    J Clin Oncol. 2019 Jun 18:JCO1900504. doi: 10.1200/JCO.19.00504.
    PubMed    


    April 2019
  32. GIRI VN, Hyatt C, Gomella LG
    Germline Testing for Men With Prostate Cancer: Navigating an Expanding New World of Genetic Evaluation for Precision Therapy and Precision Management.
    J Clin Oncol. 2019 Apr 12:JCO1802181. doi: 10.1200/JCO.18.02181.
    PubMed    


    March 2019
  33. SANCHEZ-SPITMAN A, Dezentje V, Swen J, Moes DJAR, et al
    Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study.
    J Clin Oncol. 2019;37:636-646.
    PubMed     Abstract available


    February 2019
  34. VOLTA AD, Cosentini D, Antonelli A, Pedersini R, et al
    Transformation of Prostate Adenocarcinoma Into Small-Cell Neuroendocrine Cancer Under Androgen Deprivation Therapy: Much Is Achieved But More Information Is Needed.
    J Clin Oncol. 2019;37:350-351.
    PubMed    


  35. AGGARWAL R, Huang J, Alumkal J, Feng FY, et al
    Reply to A. Dalla Volta et al.
    J Clin Oncol. 2019;37:351-352.
    PubMed    


    January 2019
  36. STOFFEL EM, McKernin SE, Brand R, Canto M, et al
    Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.
    J Clin Oncol. 2019;37:153-164.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Genetics is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: